Craving is a key component of substance use disorders(SUDs).1 In recent decades,repetitive transcranial magnetic stimulation(rTMS)has emerged as a promising treatment for individuals with SUDs by reducing their drug c...Craving is a key component of substance use disorders(SUDs).1 In recent decades,repetitive transcranial magnetic stimulation(rTMS)has emerged as a promising treatment for individuals with SUDs by reducing their drug cravings and drug-associated cues,including methamphetamine,heroin,cocaine,nicotine and alcohol.2–7 Recently,the transdiagnostic consistency of the medial prefrontal cortex(MPFC)8 and anterior cingulate cortex(ACC)9 as neural substrates underlying cue reactivity was proposed.展开更多
基金supported by the National Science and Technology Innovation 2030 Major Project of China(2021ZD0203900)NSFC grants(81822017,82271530,32241015 and 31900765)+4 种基金Science and Technology Commission of Shanghai Municipality(23ZR1480800,22QA1407900,23XD1423000 and 21YF1439700)Shanghai Municipal Commission of Health(2022JC016)Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support(20181715)Lingang Laboratory(grant no:LG-QS-202203-10)the Innovation teams of high-level universities in Shanghai,China.
文摘Craving is a key component of substance use disorders(SUDs).1 In recent decades,repetitive transcranial magnetic stimulation(rTMS)has emerged as a promising treatment for individuals with SUDs by reducing their drug cravings and drug-associated cues,including methamphetamine,heroin,cocaine,nicotine and alcohol.2–7 Recently,the transdiagnostic consistency of the medial prefrontal cortex(MPFC)8 and anterior cingulate cortex(ACC)9 as neural substrates underlying cue reactivity was proposed.
